Thea Monoprost (LT2345-PIV-02/13): Safety and Efficacy assessment of Monoprost® (unpreserved latanoprost) in comparison with Lumigan ® 0.01 % and Lumigan® 0.03% UD, in patients with open angle glaucoma or ocular hypertension, stabilized by all prostaglandin (except Monoprost®) with ocular surface intolerance.
Laufzeit: 01.01.2014 - 31.12.2017
imported
Kurzfassung
Safety and Efficacy assessment of Monoprost (unpreserved latanoprost) in comparison with Lumigan 0.01 % and Lumigan 0.03% UD, in patients with open angle glaucoma or ocular hypertension, stabilized by all prostaglandin (except Monoprost) with ocular surface intolerance.
Phase IV, international, multicentre, randomised, investigator masked, 3 months duration, 3 parallel groups, 3 X 120 evaluable patients
